The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) pathology, including the accumulation of amyloid beta (Aβ) species and tau pathology, begins decades before the onset of cognitive impairment. This long preclinical period provides an opportunity for clinical trials designed to prevent or delay the onset o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez Lopez, Cristina, Tariot, Pierre N., Caputo, Angelika, Langbaum, Jessica B., Liu, Fonda, Riviere, Marie-Emmanuelle, Langlois, Carolyn, Rouzade-Dominguez, Marie-Laure, Zalesak, Martin, Hendrix, Suzanne, Thomas, Ronald G., Viglietta, Vissia, Lenz, Rob, Ryan, J. Michael, Graf, Ana, Reiman, Eric M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562315/
https://www.ncbi.nlm.nih.gov/pubmed/31211217
http://dx.doi.org/10.1016/j.trci.2019.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562315/
https://www.ncbi.nlm.nih.gov/pubmed/31211217
http://dx.doi.org/10.1016/j.trci.2019.02.005

Ejemplares similares